MEDICINE 润色咨询

medicine

出版年份:1922 年文章数:38863 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:6.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=3小时前, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向:Meta;Meta分析<br>经验分享:审稿人两个,一个给的是小修,一个就是很刁钻,类似于拒了那样,然后编辑是让修改,也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193901, encodeId=3cc62193901e2, content=偏重的研究方向:Meta;Meta分析;生信<br>经验分享:效率还是可以,有办法accept,有困难或者是着急的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/283133ce76f34249b853d07b3e6c6d71-BFw72jTVyYmR.jpg, createdBy=7c9b9204365, createdName=Tuo988188, createdTime=Mon Mar 18 15:44:46 CST 2024, time=昨天, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后,还要under review?以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:幽门螺杆菌<br>经验分享:回顾性对照研究,6个审稿人,无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费,请问接下来是等Proof吗?通常从交版面费到online需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗?我已经修回16天了,还在with editor,也写信催过,说是会赶快给结果,然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187759, encodeId=3322218e759b6, content=返修的时候,没有说明是小修还是大修,返修1个半月过去了,还是With Editor,在返修3周的时候催过一次,也没有啥变化,这到底啥情况呀,友友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ec18217503, createdName=ms5000001544612164, createdTime=Sat Feb 17 10:19:00 CST 2024, time=2024-02-17, status=1, ipAttribution=湖北省)]
    3小时前 ms1000000779917067 来自云南省

    有没有转投meidcine成功的

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=3小时前, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向:Meta;Meta分析<br>经验分享:审稿人两个,一个给的是小修,一个就是很刁钻,类似于拒了那样,然后编辑是让修改,也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193901, encodeId=3cc62193901e2, content=偏重的研究方向:Meta;Meta分析;生信<br>经验分享:效率还是可以,有办法accept,有困难或者是着急的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/283133ce76f34249b853d07b3e6c6d71-BFw72jTVyYmR.jpg, createdBy=7c9b9204365, createdName=Tuo988188, createdTime=Mon Mar 18 15:44:46 CST 2024, time=昨天, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后,还要under review?以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:幽门螺杆菌<br>经验分享:回顾性对照研究,6个审稿人,无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费,请问接下来是等Proof吗?通常从交版面费到online需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗?我已经修回16天了,还在with editor,也写信催过,说是会赶快给结果,然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187759, encodeId=3322218e759b6, content=返修的时候,没有说明是小修还是大修,返修1个半月过去了,还是With Editor,在返修3周的时候催过一次,也没有啥变化,这到底啥情况呀,友友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ec18217503, createdName=ms5000001544612164, createdTime=Sat Feb 17 10:19:00 CST 2024, time=2024-02-17, status=1, ipAttribution=湖北省)]
    2024-01-29 苦行僧难上加难 来自江西省

    under review就是准备送外审了吗?

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=3小时前, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向:Meta;Meta分析<br>经验分享:审稿人两个,一个给的是小修,一个就是很刁钻,类似于拒了那样,然后编辑是让修改,也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193901, encodeId=3cc62193901e2, content=偏重的研究方向:Meta;Meta分析;生信<br>经验分享:效率还是可以,有办法accept,有困难或者是着急的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/283133ce76f34249b853d07b3e6c6d71-BFw72jTVyYmR.jpg, createdBy=7c9b9204365, createdName=Tuo988188, createdTime=Mon Mar 18 15:44:46 CST 2024, time=昨天, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后,还要under review?以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:幽门螺杆菌<br>经验分享:回顾性对照研究,6个审稿人,无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费,请问接下来是等Proof吗?通常从交版面费到online需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗?我已经修回16天了,还在with editor,也写信催过,说是会赶快给结果,然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187759, encodeId=3322218e759b6, content=返修的时候,没有说明是小修还是大修,返修1个半月过去了,还是With Editor,在返修3周的时候催过一次,也没有啥变化,这到底啥情况呀,友友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ec18217503, createdName=ms5000001544612164, createdTime=Sat Feb 17 10:19:00 CST 2024, time=2024-02-17, status=1, ipAttribution=湖北省)]
    2024-01-02 ms9000001415022170 来自吉林省

    sci怎么不更新medicine了

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=3小时前, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向:Meta;Meta分析<br>经验分享:审稿人两个,一个给的是小修,一个就是很刁钻,类似于拒了那样,然后编辑是让修改,也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193901, encodeId=3cc62193901e2, content=偏重的研究方向:Meta;Meta分析;生信<br>经验分享:效率还是可以,有办法accept,有困难或者是着急的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/283133ce76f34249b853d07b3e6c6d71-BFw72jTVyYmR.jpg, createdBy=7c9b9204365, createdName=Tuo988188, createdTime=Mon Mar 18 15:44:46 CST 2024, time=昨天, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后,还要under review?以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:幽门螺杆菌<br>经验分享:回顾性对照研究,6个审稿人,无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费,请问接下来是等Proof吗?通常从交版面费到online需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗?我已经修回16天了,还在with editor,也写信催过,说是会赶快给结果,然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187759, encodeId=3322218e759b6, content=返修的时候,没有说明是小修还是大修,返修1个半月过去了,还是With Editor,在返修3周的时候催过一次,也没有啥变化,这到底啥情况呀,友友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ec18217503, createdName=ms5000001544612164, createdTime=Sat Feb 17 10:19:00 CST 2024, time=2024-02-17, status=1, ipAttribution=湖北省)]
    2024-02-24 ms4000002086897803 来自北京

    偏重的研究方向:Meta;Meta分析
    经验分享:审稿人两个,一个给的是小修,一个就是很刁钻,类似于拒了那样,然后编辑是让修改,也不知道接下来会怎么样

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=3小时前, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向:Meta;Meta分析<br>经验分享:审稿人两个,一个给的是小修,一个就是很刁钻,类似于拒了那样,然后编辑是让修改,也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193901, encodeId=3cc62193901e2, content=偏重的研究方向:Meta;Meta分析;生信<br>经验分享:效率还是可以,有办法accept,有困难或者是着急的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/283133ce76f34249b853d07b3e6c6d71-BFw72jTVyYmR.jpg, createdBy=7c9b9204365, createdName=Tuo988188, createdTime=Mon Mar 18 15:44:46 CST 2024, time=昨天, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后,还要under review?以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:幽门螺杆菌<br>经验分享:回顾性对照研究,6个审稿人,无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费,请问接下来是等Proof吗?通常从交版面费到online需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗?我已经修回16天了,还在with editor,也写信催过,说是会赶快给结果,然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187759, encodeId=3322218e759b6, content=返修的时候,没有说明是小修还是大修,返修1个半月过去了,还是With Editor,在返修3周的时候催过一次,也没有啥变化,这到底啥情况呀,友友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ec18217503, createdName=ms5000001544612164, createdTime=Sat Feb 17 10:19:00 CST 2024, time=2024-02-17, status=1, ipAttribution=湖北省)]
    昨天 Tuo988188 来自广西

    偏重的研究方向:Meta;Meta分析;生信
    经验分享:效率还是可以,有办法accept,有困难或者是着急的可以聊聊

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=3小时前, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向:Meta;Meta分析<br>经验分享:审稿人两个,一个给的是小修,一个就是很刁钻,类似于拒了那样,然后编辑是让修改,也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193901, encodeId=3cc62193901e2, content=偏重的研究方向:Meta;Meta分析;生信<br>经验分享:效率还是可以,有办法accept,有困难或者是着急的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/283133ce76f34249b853d07b3e6c6d71-BFw72jTVyYmR.jpg, createdBy=7c9b9204365, createdName=Tuo988188, createdTime=Mon Mar 18 15:44:46 CST 2024, time=昨天, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后,还要under review?以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:幽门螺杆菌<br>经验分享:回顾性对照研究,6个审稿人,无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费,请问接下来是等Proof吗?通常从交版面费到online需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗?我已经修回16天了,还在with editor,也写信催过,说是会赶快给结果,然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187759, encodeId=3322218e759b6, content=返修的时候,没有说明是小修还是大修,返修1个半月过去了,还是With Editor,在返修3周的时候催过一次,也没有啥变化,这到底啥情况呀,友友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ec18217503, createdName=ms5000001544612164, createdTime=Sat Feb 17 10:19:00 CST 2024, time=2024-02-17, status=1, ipAttribution=湖北省)]
    2024-02-24 zll2020 来自四川省

    为什么OA accept with minor revise之后,还要under review?以前不都是直接接收吗

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=3小时前, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向:Meta;Meta分析<br>经验分享:审稿人两个,一个给的是小修,一个就是很刁钻,类似于拒了那样,然后编辑是让修改,也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193901, encodeId=3cc62193901e2, content=偏重的研究方向:Meta;Meta分析;生信<br>经验分享:效率还是可以,有办法accept,有困难或者是着急的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/283133ce76f34249b853d07b3e6c6d71-BFw72jTVyYmR.jpg, createdBy=7c9b9204365, createdName=Tuo988188, createdTime=Mon Mar 18 15:44:46 CST 2024, time=昨天, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后,还要under review?以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:幽门螺杆菌<br>经验分享:回顾性对照研究,6个审稿人,无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费,请问接下来是等Proof吗?通常从交版面费到online需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗?我已经修回16天了,还在with editor,也写信催过,说是会赶快给结果,然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187759, encodeId=3322218e759b6, content=返修的时候,没有说明是小修还是大修,返修1个半月过去了,还是With Editor,在返修3周的时候催过一次,也没有啥变化,这到底啥情况呀,友友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ec18217503, createdName=ms5000001544612164, createdTime=Sat Feb 17 10:19:00 CST 2024, time=2024-02-17, status=1, ipAttribution=湖北省)]
    2024-03-17 山大学医者 来自山东省

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:幽门螺杆菌
    经验分享:回顾性对照研究,6个审稿人,无尖锐问题

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=3小时前, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向:Meta;Meta分析<br>经验分享:审稿人两个,一个给的是小修,一个就是很刁钻,类似于拒了那样,然后编辑是让修改,也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193901, encodeId=3cc62193901e2, content=偏重的研究方向:Meta;Meta分析;生信<br>经验分享:效率还是可以,有办法accept,有困难或者是着急的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/283133ce76f34249b853d07b3e6c6d71-BFw72jTVyYmR.jpg, createdBy=7c9b9204365, createdName=Tuo988188, createdTime=Mon Mar 18 15:44:46 CST 2024, time=昨天, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后,还要under review?以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:幽门螺杆菌<br>经验分享:回顾性对照研究,6个审稿人,无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费,请问接下来是等Proof吗?通常从交版面费到online需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗?我已经修回16天了,还在with editor,也写信催过,说是会赶快给结果,然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187759, encodeId=3322218e759b6, content=返修的时候,没有说明是小修还是大修,返修1个半月过去了,还是With Editor,在返修3周的时候催过一次,也没有啥变化,这到底啥情况呀,友友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ec18217503, createdName=ms5000001544612164, createdTime=Sat Feb 17 10:19:00 CST 2024, time=2024-02-17, status=1, ipAttribution=湖北省)]
    2021-02-11 14697d06m38(暂无昵称)

    刚交了版面费,请问接下来是等Proof吗?通常从交版面费到online需要多久?

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=3小时前, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向:Meta;Meta分析<br>经验分享:审稿人两个,一个给的是小修,一个就是很刁钻,类似于拒了那样,然后编辑是让修改,也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193901, encodeId=3cc62193901e2, content=偏重的研究方向:Meta;Meta分析;生信<br>经验分享:效率还是可以,有办法accept,有困难或者是着急的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/283133ce76f34249b853d07b3e6c6d71-BFw72jTVyYmR.jpg, createdBy=7c9b9204365, createdName=Tuo988188, createdTime=Mon Mar 18 15:44:46 CST 2024, time=昨天, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后,还要under review?以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:幽门螺杆菌<br>经验分享:回顾性对照研究,6个审稿人,无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费,请问接下来是等Proof吗?通常从交版面费到online需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗?我已经修回16天了,还在with editor,也写信催过,说是会赶快给结果,然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187759, encodeId=3322218e759b6, content=返修的时候,没有说明是小修还是大修,返修1个半月过去了,还是With Editor,在返修3周的时候催过一次,也没有啥变化,这到底啥情况呀,友友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ec18217503, createdName=ms5000001544612164, createdTime=Sat Feb 17 10:19:00 CST 2024, time=2024-02-17, status=1, ipAttribution=湖北省)]
    2024-02-29 ms9000000472246077 来自山东省

    请问大家revise以后都接收了吗?我已经修回16天了,还在with editor,也写信催过,说是会赶快给结果,然而并没有

    5

    展开5条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=3小时前, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向:Meta;Meta分析<br>经验分享:审稿人两个,一个给的是小修,一个就是很刁钻,类似于拒了那样,然后编辑是让修改,也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193901, encodeId=3cc62193901e2, content=偏重的研究方向:Meta;Meta分析;生信<br>经验分享:效率还是可以,有办法accept,有困难或者是着急的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/283133ce76f34249b853d07b3e6c6d71-BFw72jTVyYmR.jpg, createdBy=7c9b9204365, createdName=Tuo988188, createdTime=Mon Mar 18 15:44:46 CST 2024, time=昨天, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后,还要under review?以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:幽门螺杆菌<br>经验分享:回顾性对照研究,6个审稿人,无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费,请问接下来是等Proof吗?通常从交版面费到online需要多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190169, encodeId=8fef2190169b0, content=请问大家revise以后都接收了吗?我已经修回16天了,还在with editor,也写信催过,说是会赶快给结果,然而并没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d0e5616056, createdName=ms9000000472246077, createdTime=Thu Feb 29 19:17:27 CST 2024, time=2024-02-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187759, encodeId=3322218e759b6, content=返修的时候,没有说明是小修还是大修,返修1个半月过去了,还是With Editor,在返修3周的时候催过一次,也没有啥变化,这到底啥情况呀,友友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ec18217503, createdName=ms5000001544612164, createdTime=Sat Feb 17 10:19:00 CST 2024, time=2024-02-17, status=1, ipAttribution=湖北省)]
    2024-02-17 ms5000001544612164 来自湖北省

    返修的时候,没有说明是小修还是大修,返修1个半月过去了,还是With Editor,在返修3周的时候催过一次,也没有啥变化,这到底啥情况呀,友友们

    8

    展开8条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分